Showing results (161-170 of 192) with videos related to

Sort By:
Pageof 20
Leukemia|April 1, 2005
Hematopoietic cell transplantation from HLA-identical sibling donors after low-dose radiation-based conditioning for treatment of CMLF R Kerbauy, R Storb, U Hegenbart, et al.
British Journal of Haematology|April 22, 2005
Prognostic relevance of 'early-onset' graft-versus-host disease following non-myeloablative haematopoietic cell transplantationMarco Mielcarek, Lauri Burroughs, Wendy Leisenring, et al.
Blood|May 9, 2009
TLI and ATG conditioning with low risk of graft-versus-host disease retains antitumor reactions after allogeneic hematopoietic cell transplantation from related and unrelated donorsHolbrook E Kohrt, Brit B Turnbull, Kartoosh Heydari, et al.
Blood|October 4, 2003
Adoptive immunotherapy with donor lymphocyte infusions after allogeneic hematopoietic cell transplantation following nonmyeloablative conditioningWolfgang A Bethge, Ute Hegenbart, Monic J Stuart, et al.
Blood|July 1, 2004
Kinetics of engraftment in patients with hematologic malignancies given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioningFrédéric Baron, Jennifer E Baker, Rainer Storb, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 20, 2011
Long-term outcome of patients with metastatic breast cancer treated with high-dose chemotherapy and transplantation of purified autologous hematopoietic stem cellsAntonia M S Müller, Holbrook E K Kohrt, Steven Cha, et al.
The New England Journal of Medicine|September 30, 2005
Protective conditioning for acute graft-versus-host diseaseRobert Lowsky, Tsuyoshi Takahashi, Yin Ping Liu, et al.
Blood|July 12, 2003
Allografting with nonmyeloablative conditioning following cytoreductive autografts for the treatment of patients with multiple myelomaDavid G Maloney, Arthur J Molina, Firoozeh Sahebi, et al.
Annals of the New York Academy of Sciences|July 19, 2001
Nonmyeloablative hematopoietic cell transplantation. Replacing high-dose cytotoxic therapy by the graft-versus-tumor effectL Feinstein, B Sandmaier, D Maloney, et al.
Blood|October 24, 2002
Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induce durable complete chimerism and sustained remissions in patients with hematological diseasesDietger Niederwieser, Michael Maris, Judith A Shizuru, et al.
Pageof 20